| Apoptosis by death factor S Nagata cell 88 (3), 355-365, 1997 | 6083 | 1997 |
| The Fas death factor S Nagata, P Golstein Science 267 (5203), 1449-1456, 1995 | 5231 | 1995 |
| A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD M Enari, H Sakahira, H Yokoyama, K Okawa, A Iwamatsu, S Nagata Nature 391 (6662), 43, 1998 | 3943 | 1998 |
| Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. NS Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA Nature 356 (6367), 314-317, 1992 | 3334 | 1992 |
| The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis N Itoh, S Yonehara, AI Ishii, M Yonehara, SI Mizushima, M Sameshima, ... Cell 66 (2), 233-243, 1991 | 3281 | 1991 |
| Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family T Suda, T Takahashi, P Golstein, S Nagata Cell 75 (6), 1169-1178, 1993 | 3006 | 1993 |
| Lethal effect of the anti-Fas antibody in mice J Ogasawara, R Watanabe-Fukunaga, M Adachi, A Matsuzawa, ... Nature 364 (6440), 806, 1993 | 2175 | 1993 |
| Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis H Sakahira, M Enari, S Nagata Nature 391 (6662), 96, 1998 | 1999 | 1998 |
| pEF-BOS, a powerful mammalian expression vector. S Mizushima, S Nagata Nucleic acids research 18 (17), 5322, 1990 | 1841 | 1990 |
| Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity D Kagi, F Vignaux, B Ledermann, K Burki, V Depraetere, S Nagata, ... Science 265 (5171), 528-530, 1994 | 1815 | 1994 |
| Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand T Takahashi, M Tanaka, CI Brannan, NA Jenkins, NG Copeland, T Suda, ... Cell 76 (6), 969-976, 1994 | 1785 | 1994 |
| Identification of a factor that links apoptotic cells to phagocytes R Hanayama, M Tanaka, K Miwa, A Shinohara, A Iwamatsu, S Nagata Nature 417 (6885), 182, 2002 | 1177 | 2002 |
| Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis M Enari, RV Talanian, WW Wrong, S Nagata Nature 380 (6576), 723, 1996 | 1134 | 1996 |
| A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. N Itoh, S Nagata Journal of Biological Chemistry 268 (15), 10932-10937, 1993 | 1075 | 1993 |
| Apoptotic DNA fragmentation S Nagata Experimental cell research 256 (1), 12-18, 2000 | 1063 | 2000 |
| Fas and Fas ligand: lpr and gld mutations S Nagata, T Suda Immunology today 16 (1), 39-43, 1995 | 1050 | 1995 |
| Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor S Nagata, M Tsuchiya, S Asano, Y Kaziro, T Yamazaki, O Yamamoto, ... Nature 319 (6052), 415, 1986 | 1039 | 1986 |
| The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. R Watanabe-Fukunaga, CI Brannan, N Itoh, S Yonehara, NG Copeland, ... The Journal of Immunology 148 (4), 1274-1279, 1992 | 1004 | 1992 |
| Involvement of an ICE-like protease in Fas-mediated apoptosis M Enari, H Hug, S Nagata Nature 375 (6526), 78, 1995 | 935 | 1995 |
| Fas ligand-induced apoptosis S Nagata Annual review of genetics 33 (1), 29-55, 1999 | 911 | 1999 |
